Important Dates

  • Registration Opens: Apr 17, 2017
  • Abstract Submission Opens: May 8, 2017 
  • Abstract Submission Closes: Jun 22, 2017, 5:00 p.m. ET 
  • Early Bird Registration Deadline: Jul 27, 2017
  • Hotel Reservation Deadline: Aug 15, 2017 

ASM Co-Chair

Keith Rodvold, Pharm.D., FCCP, FIDSA
Colleges of Pharmacy and Medicine
University of Illinois at Chicago
Chicago, IL

ESCMID Co-Chair 

William Hope, BMBS, FRACP, FRCPA, PhD
University of Liverpool
United Kingdom 

Program Committee Members


Follow #ASMESCMID on Twitter for the latest updates on this meeting! 

*ASM Response to White House Executive Order Regarding Travel and Immigration

 

The ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, will be held September 6–8, 2017, at the Boston Park Plaza Hotel in Boston, MA. 

Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by National and International bodies. There are relatively few agents in developmental pipelines and a paucity of identified microbiological targets that can be exploited for drug development. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development for AMR. 

 

 

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

94883